imipenem, anhydrous has been researched along with Leukemia, Pre-B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourdier, A; Haouy, S; Marchandin, H; Michon, AL; Saumet, L; Sirvent, N | 1 |
| Demircioğlu, F; Oren, H | 1 |
2 other study(ies) available for imipenem, anhydrous and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia.
Topics: Anti-Bacterial Agents; Bacteremia; Child; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Methylobacteriaceae; Mucous Membrane; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 2014 |
Ecthyma gangrenosum: sign of Pseudomonas aeruginosa bacteremia.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Child; Ecthyma; Female; Humans; Imipenem; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |